We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00677716
Recruitment Status : Completed
First Posted : May 14, 2008
Last Update Posted : April 24, 2014
Sponsor:
Information provided by (Responsible Party):
Peregrine Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2011
  Study Completion Date : November 2011